Table 2.

Various treatments and treatment combinations used and their corresponding concentrations.

Treatment	Concentrations of Drug or formulation used (µg/mL)
Liposomal Cyclic Peptide	2, 4, 8
Liposomal Azithromycin	1, 2, 4
Liposomal Rifampicin	4, 8, 16
Liposomal Rifampicin + Liposomal Cyclic peptide (LC)	4, 8, 16 + 2, 4, 8
Liposomal Azithromycin + Liposomal Cyclic peptide (LC)	1, 2, 4 + 2, 4, 8
Liposomal Azithromycin-Cyclic Peptide (LE)	1, 2, 4 + 2, 4, 8
Liposomal Rifampicin-Cyclic Peptide (LE)	4, 8, 16 + 2, 4, 8
Free Cyclic Peptide	2, 4, 8
Free Azithromycin	1, 2, 4
Free Rifampicin	4, 8, 16
Free Azithromycin + Cyclic Peptide	1, 2, 4 + 2, 4, 8
Free Rifampicin + Cyclic Peptide	4, 8, 16 + 2, 4, 8